Cargando…

The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation

Both clinical and experimental evidence have firmly established that chronic pancreatitis, in particular in the context of Kras oncogenic mutations, predisposes to pancreatic ductal adenocarcinoma (PDAC). However, the repertoire of molecular mediators of pancreatitis involved in Kras-mediated initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loncle, C, Molejon, M I, Lac, S, Tellechea, J I, Lomberk, G, Gramatica, L, Fernandez Zapico, M F, Dusetti, N, Urrutia, R, Iovanna, J L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973346/ https://www.ncbi.nlm.nih.gov/pubmed/27415425 http://dx.doi.org/10.1038/cddis.2016.202

Ejemplares similares

Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
por: Grasso, Daniel, et al.
Publicado: (2015)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1
por: Grasso, Daniel, et al.
Publicado: (2014)

The VMP1-Beclin 1 interaction regulates autophagy induction
por: Molejon, Maria I., et al.
Publicado: (2013)

Genetic inactivation of the pancreatitis-inducible gene Nupr1 impairs PanIN formation by modulating Kras(G12D)-induced senescence
por: Grasso, D, et al.
Publicado: (2014)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Kras(G12D) induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
por: Mathison, Angela J., et al.
Publicado: (2021)

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)

Autophagy Induced during Pancreatitis Promotes KRAS-Dependent Transformation in the Pancreas
por: Iovanna, Juan L.
Publicado: (2016)

The promise of epigenomic therapeutics in pancreatic cancer
por: Lomberk, Gwen A, et al.
Publicado: (2016)

IER3 in pancreatic carcinogenesis
por: Molejon, Maria Inés, et al.
Publicado: (2015)

A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS
por: Ropolo, Alejandro, et al.
Publicado: (2020)

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Mitochondrial Dynamics and VMP1-Related Selective Mitophagy in Experimental Acute Pancreatitis
por: Vanasco, Virginia, et al.
Publicado: (2021)

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023)

Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2012)

Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
por: Cano, Carla E, et al.
Publicado: (2021)

Autophagy in Pancreatic Cancer
por: Grasso, Daniel, et al.
Publicado: (2012)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
por: Gajate, Consuelo, et al.
Publicado: (2021)

Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
por: Liu, Juan, et al.
Publicado: (2021)

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma
por: Molejon, María Inés, et al.
Publicado: (2018)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
por: Urrutia, Guillermo, et al.
Publicado: (2021)

Ubiquitination Is a Novel Post-Translational Modification of VMP1 in Autophagy of Human Tumor Cells
por: Renna, Felipe J., et al.
Publicado: (2023)

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
por: Bian, Benjamin, et al.
Publicado: (2017)

VMP1 Establishes ER-Microdomains that Regulate Membrane Contact Sites and Autophagy
por: Tábara, Luis-Carlos, et al.
Publicado: (2016)

VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy
por: Lin, Wanzun, et al.
Publicado: (2021)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2019)

Roles of VMP1 in Autophagy and ER–Membrane Contact: Potential Implications in Neurodegenerative Disorders
por: Wang, Panpan, et al.
Publicado: (2020)

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling
por: Secq, V, et al.
Publicado: (2015)

Essential role for autophagy protein VMP1 in maintaining neuronal homeostasis and preventing axonal degeneration
por: Wang, Panpan, et al.
Publicado: (2021)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer
por: Dai, Manxiong, et al.
Publicado: (2022)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023)

Differential Cell Susceptibilities to Kras(G12D) in the Setting of Obstructive Chronic Pancreatitis
por: Shi, Chanjuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5bd9iadedb3p6vd99olrba07o4